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There is increasing evidence that diabetic retinopathy is a primary neuropathological 2 
disorder that precedes the microvascular pathology associated with later stages of the 3 
disease. Recently, we found evidence for altered functional properties of synaptic AMPA 4 
receptors in A17, but not AII amacrine cells in the mammalian retina and the observed 5 
changes were consistent with an upregulation of the GluA2 subunit, a key determinant of 6 
functional properties of AMPA receptors, including Ca2+ permeability and I-V rectification 7 
properties. Here, we have investigated functional changes of extrasynaptic AMPA 8 
receptors in AII amacrine cells evoked by diabetes. With patch-clamp recording of 9 
nucleated patches from retinal slices, we measured Ca2+ permeability and I-V rectification 10 
in rats with ~3 weeks of streptozotocin-induced diabetes and age-matched, non-injected 11 
controls. Under bi-ionic conditions ([Ca2+]out=30 mM, [Cs+]in=171 mM), the reversal 12 
potential of AMPA-evoked currents indicated a significant reduction of Ca2+ permeability 13 
in diabetic animals (Erev=-17.7 mV, PCa/PCs=1.39) compared to normal animals (Erev=-7.7 14 
mV, PCa/PCs=2.35). Insulin treatment prevented the reduction of Ca2+ permeability. I-V 15 
rectification was examined by calculating a rectification index (RI) as the ratio of the 16 
AMPA-evoked conductance at +40 and -60 mV. The degree of inward rectification in 17 
patches from diabetic animals (RI=0.48) was significantly reduced compared to that in 18 
normal animals (RI=0.30). These results suggest that diabetes evokes a change in the 19 
functional properties of extrasynaptic AMPA receptors of AII amacrine cells. These 20 
changes could be representative for extrasynaptic AMPA receptors elsewhere in AII 21 
amacrine cells and suggest that synaptic and extrasynaptic AMPA receptors are 22 
differentially regulated. 23 
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Key words: amacrine cells; calcium-permeable AMPA receptors; diabetes; retina 25 
 3 
INTRODUCTION 26 
Diabetic retinopathy is both the most common cause of legal blindness in working-age 27 
adults (reviewed by Gardner et al. 2011) and one of the most common complications of 28 
diabetes mellitus (henceforth referred to as diabetes). Although traditionally considered a 29 
microvascular disease, there is increasing evidence that diabetic retinopathy partially 30 
involves a dysfunction of the neural retina that precedes the microvascular pathology 31 
typically observed at later stages of the disease (Antonetti et al. 2012; Simó and Hernández 32 
2014). Supporting the hypothesis that pre-vascular diabetic retinopathy could be a primary 33 
neuropathological disorder, is the accumulating evidence for diabetes-evoked changes in 34 
the functional state of specific neurotransmitter systems, with changes in expression and 35 
regulation of AMPA receptor subunits being subject to detailed investigations (Castilho et 36 
al. 2012; Gowda et al. 2011; Ng et al. 2004; Santiago et al. 2006, 2008; Semkova et al. 2010). 37 
Of particular interest is the GluA2 subunit, which plays a crucial role in determining 38 
important functional properties of AMPA receptors such as Ca2+ permeability, current-39 
voltage (I-V) rectification, single-channel conductance, and kinetics (reviewed by Cull-40 
Candy et al. 2006; Greger and Esteban 2007; Traynelis et al. 2010). Exposing retinal cultures 41 
enriched in amacrine cells to elevated glucose concentration induces a reduction in 42 
agonist-evoked Ca2+ responses mediated by Ca2+-permeable AMPA receptors, most likely 43 
caused by a concomitant increase in the expression of the GluA2 subunit (Santiago et al. 44 
2006). It is difficult to directly measure the Ca2+ permeability of AMPA receptors in intact 45 
systems, however, and changes in this important functional property is typically inferred 46 
indirectly by measuring changes in subunit expression or correlated changes in 47 
electrophysiological properties. 48 
 Recently, we used an experimental model of diabetes in mature rats to study 49 
synaptic transmission in the rod bipolar microcircuit and examined how diabetes 50 
differentially affects the functional properties of synaptic AMPA receptors expressed by 51 
AII and A17 amacrine cells, two important and well-characterized types of rod amacrine 52 
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cells in the mammalian retina (Castilho et al. 2015). The AII and A17 amacrine cells are 53 
postsynaptic to glutamatergic rod bipolar cells at dyad synapses (Kolb and Famiglietti 54 
1974; Raviola and Dacheux 1987) and there is evidence that Ca2+-permeable AMPA 55 
receptors are involved in mediating synaptic input from rod bipolar cells to both types of 56 
amacrine cells (Chávez et al. 2006; Osswald et al. 2007; Singer and Diamond 2003). 57 
Whereas the A17 amacrine cell provides a GABAergic reciprocal inhibitory synapse back 58 
onto the rod bipolar cell (Nelson and Kolb 1985; Raviola and Dacheux 1987), the AII 59 
amacrine cell outputs its signal to ON-cone bipolar cells via electrical synapses (Kolb and 60 
Famiglietti 1974; McGuire et al. 1984; Strettoi et al. 1992, 1994) and to OFF-cone bipolar 61 
cells via inhibitory, glycinergic synapses (Pourcho and Goebel 1985; Sassoè-Pognetto et al. 62 
1994; Strettoi et al. 1992, 1994). In addition to the glutamatergic input from rod bipolar 63 
cells at the arboreal dendrites, AII amacrine cells also receive glutamatergic input from 64 
some types of OFF-cone bipolar cells at the lobular appendages (Kolb and Famiglietti 1974; 65 
Strettoi et al. 1992; Veruki et al. 2003). The main result of our recent study was that 66 
diabetes evoked changes in the functional properties of synaptic AMPA receptors of A17 67 
amacrine cells, including reduced Ca2+ responses mediated by Ca2+-permeable AMPA 68 
receptors, and the observed changes were consistent with an upregulation of the GluA2 69 
subunit (Castilho et al. 2015). We did not find evidence for similar changes of synaptic 70 
AMPA receptors in AII amacrine cells. 71 
 There is evidence, however, that AII amacrine cells express extrasynaptic AMPA 72 
receptors with relatively high Ca2+ permeability at their somata (Mørkve et al. 2002), 73 
leaving open the possibility that diabetes might change extrasynaptic AMPA receptors on 74 
these cells which would not have been detected in our previous study of synaptic 75 
receptors. On this basis, we decided to investigate whether experimentally induced 76 
diabetes alters functional properties of somatic extrasynaptic AMPA receptors of AII 77 
amacrine cells. We were particularly interested in potential changes of Ca2+ permeability, 78 
which is of particular importance for neuronal signaling and plasticity (Higley and 79 
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Sabatini 2012). We recorded from nucleated patches isolated from AII amacrine cells and 80 
measured the relative Ca2+ permeability (under bi-ionic conditions) and the I-V 81 
rectification properties of the AMPA receptors. Here, we find that diabetes reduces both 82 
Ca2+ permeability and I-V inward rectification of extrasynaptic AMPA receptors in AII 83 
amacrine cells, suggesting that diabetes differentially regulates synaptic and extrasynaptic 84 
AMPA receptors in these cells. 85 
 86 
METHODS 87 
 Retinal slice preparation. General aspects of the methods have previously been 88 
described in detail (Hartveit 1996; Mørkve et al. 2002). Female albino rats (Wistar HanTac; 89 
5 - 8 weeks postnatal) were deeply anaesthetized with isoflurane in oxygen and killed by 90 
cervical dislocation (procedure approved under the surveillance of the Norwegian Animal 91 
Research Authority). Vertical retinal slices were visualized (Axioskop 2 FS, Zeiss) with a 92 
×40 water immersion objective (0.9 NA; Olympus) and infrared differential interference 93 
contrast (IR-DIC) videomicroscopy. Recordings were carried out at room temperature (22 - 94 
25°C). 95 
 96 
 Solutions and drug application. The standard extracellular perfusing solution was 97 
continuously bubbled with 95% O2 - 5% CO2 and had the following composition (in mM): 98 
125 NaCl, 25 NaHCO3, 2.5 KCl, 2.5 CaCl2, 1 MgCl2, 10 glucose, pH 7.4. In recordings 99 
designed to measure the relative Ca2+ permeability of AMPA receptor channels, recording 100 
pipettes were filled with an intracellular solution of the following composition (in mM): 101 
150 CsCl, 5 Hepes, 2 MgATP and 10 EGTA. The pH was adjusted to 7.3 with CsOH, 102 
increasing the total Cs+ concentration to 171 mM. The osmolality of this intracellular 103 
solution was ~290 mOsm/kg. In recordings designed to measure the I-V rectification 104 
properties, the pipettes were filled with an intracellular solution of the following 105 
composition (in mM): 125 CsCH3SO3, 15 TEA-Cl, 8 NaCl, 10 Hepes, 1 CaCl2, 4 MgATP and 106 
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5 EGTA. Spermine (Research Biochemicals International, Natick, MA, USA) was added at 107 
a concentration of 100 µM, Lucifer yellow (Sigma-Aldrich) was added at a concentration of 108 
1 mg/ml and pH was adjusted to 7.3 with CsOH. The osmolality of this intracellular 109 
solution was ~315 mOsm/kg. The data acquisition software (PatchMaster; HEKA 110 
Elektronik, Lambrecht/Pfalz, Germany) corrected all holding potentials for liquid junction 111 
potentials on-line. Theoretical liquid junction potentials were calculated with JPCalcW 112 
(Axon Instruments, Union City, CA, USA). 113 
 In experiments for measuring Ca2+ permeability of AMPA receptor channels in 114 
nucleated patches, S-AMPA (termed "AMPA" for simplicity; 1.6 mM; Tocris Bioscience, 115 
Bristol, UK) was applied from a theta-tube application pipette (nominal septum thickness 116 
~117 µm; final tip diameter 250 - 300 µm; Hilgenberg, Malsfeld, Germany). The pipette tip 117 
with the nucleated patch was positioned near the interface between control solution and 118 
agonist-containing solution continuously flowing out of each barrel, about 100 µm 119 
downstream from the tip of the application pipette. The solution flow rate (5 ml/h) was 120 
maintained by syringe pumps (KDS220; KD Scientific, Boston, MA, USA) controlled by the 121 
PatchMaster software. Concentration jumps of agonist to a nucleated patch were applied 122 
by rapidly moving the position of the application pipette and thus the solution interface 123 
while the recording pipette remained still. Agonist pulses were applied every 4 s. The 124 
application pipette was mounted on a piezo actuator (LSS-3100/PZS-100HS; Burleigh 125 
Instruments, Fishers, NY, USA) operated by an amplifier (PZ-150M; Burleigh Instruments) 126 
stimulated with square-wave voltage pulses from the ITC-16 interface built into the 127 
recording amplifier (see below). Before being fed to the amplifier, the voltage pulses were 128 
smoothened by an electronic circuit consisting of an RC-filter (time constant 1 ms) and an 129 
inductive element to counteract oscillations. The 10 - 90% solution exchange time (~250 - 130 
300 µs) was measured as the change in liquid junction current of an open patch pipette 131 
filled with 0.9% NaCl when moved from a solution of 0.9% NaCl to a solution of 0.09% 132 
NaCl. However, for a nucleated patch the measured exchange time represents an 133 
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underestimation of the true exchange time. To establish bi-ionic conditions during 134 
measurements of Ca2+ permeability, the nucleated patches were exposed to an 135 
extracellular solution containing (mM) 30 CaCl2, 100 N-methyl-D-glucamine (NMDG), 10 136 
Hepes and 25 glucose (pH adjusted to 7.4 with HCl). AMPA was dissolved in the same 137 
solution. For measurements of Ca2+ permeability, the reference electrode (Ag-AgCl wire) 138 
was connected to the recording chamber via an electrolyte-agar bridge to avoid directly 139 
exposing the reference electrode to changes of the extracellular solution. 140 
 141 
 Electrophysiological recording and data acquisition. Patch pipettes were pulled from 142 
thick-walled borosilicate glass (outer diameter, 1.5 mm; inner diameter, 0.86 mm). The 143 
open-tip resistance of the pipettes ranged from 5 to 7 MΩ when filled with intracellular 144 
solution. Voltage-clamp recordings were performed with an EPC9-dual amplifier (HEKA 145 
Elektronik) controlled by PatchMaster software. After establishing a GΩ-seal (initial seal 146 
resistance 2 - 25 GΩ), currents caused by the recording electrode capacitance (Cfast) were 147 
automatically measured and neutralized by the amplifier. After breaking into the cell, 148 
currents caused by the cell membrane capacitance (Cslow) were partially neutralized by the 149 
amplifier. To establish a nucleated patch recording, the pipette was slowly withdrawn 150 
after establishing the whole-cell recording configuration, while continuous light suction 151 
(~50 mbar) was applied to the pipette. When a nucleated patch was successfully isolated, 152 
the reduced membrane capacitance resulted in capacitative current transients of the 153 
opposite polarity that were cancelled by re-adjustment of the Cslow neutralization circuitry. 154 
The sampling interval was set to 50 µs and before sampling, signals were low-pass filtered 155 
(analog 3- and 4-pole Bessel filters in series) with a corner frequency (-3 dB) of 4 kHz. 156 
 157 
 Experimental model of type 1 diabetes. As in our previous study (Castilho et al. 2015), 158 
diabetes was induced in 4-week old rats with a single intraperitoneal injection of 159 
streptozotocin (65 mg/kg body weight), a toxin that kills β cells of the pancreatic islets of 160 
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Langerhans (Lenzen 2008). Animals used for control experiments did not receive any 161 
injections. Streptozotocin was stored at -20°C until the day of injection when it was 162 
dissolved in 10 mM Na-citrate buffer (pH 4.5). After injection, each rat was returned to its 163 
home cage and tested for development of diabetes by measuring the blood glucose 164 
concentration two days later. Blood glucose was measured with a hand-held glucometer 165 
(Contour Glucometer, Bayer) by collecting a drop of blood from the tail. The highest 166 
concentration we could measure with our glucometer was 600 mg/dl. Rats with blood 167 
glucose concentration exceeding 250 mg/dl were considered diabetic. At the day of the 168 
experiment diabetes was again verified by measuring blood glucose. Animals with 169 
diabetes were used for electrophysiological experiments 22 ± 0.8 days (range 18 - 26 days) 170 
after injection with streptozotocin. At the time of the experiments, the diabetic animals 171 
were between 6 and 8 weeks of age and the control animals were between 5 and 7 weeks 172 
of age. All animals were kept on a 12/12 light/dark cycle with free access to food and 173 
water. 174 
 When rats received treatment with insulin (Sigma-Aldrich), diabetes was first 175 
verified by measuring blood glucose two days after streptozotocin injection and then 176 
insulin was administered subcutaneously twice every day until the day of the experiment. 177 
During the first two days of insulin treatment, glucose concentration was measured twice 178 
daily and the dose of insulin was adjusted between 2-7 units to maintain the blood glucose 179 
concentration lower than 250 mg/dl. After the third day of insulin treatment, we found 180 
that administration of 6 units of insulin twice each day resulted in adequate glucose levels 181 
and this treatment continued without further adjustments until the day of the experiment. 182 
During this period, blood glucose concentration was measured once daily, before the 183 
second injection of insulin. 184 
 185 
 General data analysis. Data were analyzed with FitMaster (HEKA Elektronik), IGOR 186 
Pro (WaveMetrics, Lake Oswego, OR, USA), AxoGraph X (AxoGraph Scientific, Sydney, 187 
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Australia), Excel (Microsoft, Redmond, WA, USA) and GraphPad Prism (GraphPad 188 
Software, La Jolla, CA, USA). The peak amplitude of AMPA-evoked currents was 189 
measured as the mean amplitude between two vertical cursors positioned close to the 190 
peak current response as identified by eye. Data points of I-V relationships were fitted by 191 
third- to sixth-order polynomial functions. The order of the polynomial function was kept 192 
as low as possible while still getting a good fit as determined by eye. Reversal potentials 193 
(Erevs) were determined by the intersection of the fitted line with the abscissa. As a 194 
verification, we also measured the Erevs by fitting a line to the two data points closest to the 195 
presumed Erev (i.e. the lowest amplitude inward and outward currents). The results were 196 
very similar to those obtained by fitting all data points with polynomial functions. To 197 
quantify the degree of rectification of I-V relationships, we used the following equation to 198 
calculate a rectification index (RI) that expresses the ratio of chord conductance at +40 mV 199 




 ,       (1) 201 
where I+40 and I-60 are the currents at +40 mV and -60 mV, respectively, and Erev is the 202 
reversal potential in mV. Data are presented as means ± SEM (n = number of cells). 203 
Statistical analysis with comparisons between two groups (normal, diabetes) were 204 
performed using Student's two-tailed t test (unpaired) and comparisons between three 205 
groups (normal, diabetes, insulin-treated diabetes) were performed using analysis of 206 
variance (ANOVA) followed by Tukey's multiple comparison procedure to obtain 207 
adjusted P-values. Differences were considered statistically significant at the P < 0.05 level. 208 
The number of individual traces included in the averaged traces in the figures is stated for 209 
each case. For illustration purposes, most raw data records were low-pass filtered (digital 210 
nonlagging Gaussian filter, -3 dB at 500 Hz – 2 kHz). 211 
 212 
 10 
 Determination of Ca2+ permeability. To determine the relative Ca2+ permeability, bi-213 
ionic conditions were established by recording with an intracellular solution containing 214 
Cs+ (nominally 171 mM) as the only permeant cation and an extracellular solution 215 
containing Ca2+ (nominally 30 mM) as the only permeant cation. Monovalent cations (Na+ 216 
and K+) were substituted with NMDG+ because AMPA receptors are not measurably 217 
permeable to this cation (Iino et al. 1990; Jonas and Sakmann 1992). Erev was determined 218 
from currents evoked by application of AMPA at a series of holding potentials. The 219 
relative permeability of Ca2+ compared with Cs+ (PCa/PCs) was subsequently calculated 220 
from the following equation derived from the Goldman-Hodgkin-Katz constant-field 221 








exp ErevF RT( ) exp(ErevF / RT )+1[ ]
4
,   (2) 224 
 225 
where F is Faraday's constant, R is the universal gas constant, T is the absolute 226 
temperature, and PCa and PCs represent the permeability coefficients of Ca2+ and Cs+, 227 
respectively. Other ions are not taken into account and it is assumed that [Ca2+]in and 228 
[Cs+]out are zero. The concentrations were corrected by multiplying by activity coefficients 229 
(0.551 for Ca2+ and 0.707 for Cs+; see Mørkve et al. 2002 for details). 230 
 231 
Fig. 1 near here 232 
 233 
RESULTS 234 
 Identification of AII amacrine cells in retinal slices and isolation of nucleated patches. 235 
In recordings designed to estimate the relative Ca2+ permeability of AMPA receptors in 236 
nucleated patches from AII amacrine cells, it was not possible to verify the identity of the 237 
recorded cells with fluorescence microscopy because the requirement for bi-ionic 238 
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conditions excluded the addition of Lucifer yellow to the intracellular solution. 239 
Considerable care was therefore taken to target cells that displayed the complete 240 
morphological characteristics of AII amacrines, as judged by the appearance of retinal 241 
slices imaged with IR-DIC videomicroscopy (Fig. 1A). Specifically, the criteria were the 242 
location of the cell body at the border of the inner nuclear layer and the inner plexiform 243 
layer and the presence of a thick apical dendrite descending into the inner plexiform layer. 244 
In addition, immediately following the establishment of the whole-cell configuration, we 245 
verified that 5 mV depolarizing test pulses (5 ms duration) from a holding potential of -60 246 
mV evoked the characteristic inward action currents corresponding to unclamped action 247 
potentials (Fig. 1B) that depend on TTX-sensitive voltage-gated Na+ channels (Mørkve et 248 
al. 2002; Veruki et al. 2003). In previous studies, we have found that all cells visually 249 
targeted by the above criteria that also subsequently display the characteristic action 250 
currents, can be positively identified as AII amacrine cells when examined with 251 
fluorescence microscopy (Mørkve et al. 2002; Veruki et al. 2003). Only cells that satisfied 252 
these selection criteria have been included in the material reported here. In recordings 253 
from nucleated patches where the goal was to study I-V rectification properties, Lucifer 254 
yellow was added to the intracellular solution and fluorescence microscopy could be used 255 
to verify the identity of the cells we recorded from. 256 
 For our study, we used a total of 9 normal, 8 diabetic, and 3 insulin-treated rats. For 257 
the rats injected with streptozotocin, the blood glucose concentration ranged from 290 to 258 
≥600 mg/dl two days after injection and from 537 to ≥600 mg/dl at the day of the 259 
experiment. Before injection, the blood glucose in these rats was 89 ± 3 mg/dl (range 76 - 260 
101 mg/dl), similar to the concentration measured in four normal controls tested at the 261 
day of the experiment (82 ± 6 mg/dl; range 67 - 94 mg/dl). 262 
  263 
 AMPA-evoked currents in nucleated patches. Nucleated patches (Fig. 1C) voltage-264 
clamped at -60 mV were transiently exposed to AMPA (1.6 mM) using a theta-tube fast-265 
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application system. In all cases, the nucleated patches responded with an inward current 266 
that rose to a peak followed by an exponential decay to a much smaller steady-state level 267 
during sustained agonist application (Fig. 1D), corresponding to rapid and strong 268 
desensitization (Mørkve et al. 2002; Veruki et al. 2003). Previous work indicates that the 269 
receptors mediating the response to AMPA are high-affinity AMPA / low-affinity kainate 270 
receptors, as opposed to high-affinity kainate / low-affinity AMPA receptors (Mørkve et 271 
al. 2002). 272 
 273 
Fig. 2 near here 274 
 275 
 Ca2+ permeability of AMPA receptor channels in nucleated patches from normal and 276 
diabetic rats. To study the selectivity of the AMPA receptor channels for Ca2+ ions, we 277 
recorded agonist-evoked responses in nucleated patches under bi-ionic conditions with 278 
nominal concentrations of 171 mM Cs+ intracellularly and 30 mM Ca2+ extracellularly (see 279 
METHODS). Figure 2, A and B, shows an example of responses evoked by AMPA (1.6 280 
mM) at a series of holding potentials together with the corresponding I-V curve for the 281 
peak response (Erev = -4.0 mV). Because the steady-state response component in some 282 
patches was too small for accurate measurement, it was not used for analysis. The average 283 
Erev for nucleated patches isolated from normal animals was -7.7 ± 0.9 mV (Fig. 2E; range -284 
11.3 to -4.0 mV; n = 7 patches). From these values, the permeability ratio (PCa/PCs) of the 285 
AMPA receptors expressed in the cell bodies of AII amacrines was calculated according to 286 
eqn (2), yielding an average value of 2.35 ± 0.11 (range 1.92 – 2.89). These results are very 287 
similar to those reported in the earlier study by Mørkve et al. (2002; Erev = -10.7 ± 1.8 mV; 288 
PCa/PCs = 2.1 ± 0.21). 289 
 Nucleated patches isolated from AII amacrine cells from diabetic animals were 290 
investigated identically to nucleated patches from normal animals. Figure 2, C and D, 291 
shows an example of responses evoked by AMPA (1.6 mM) at a series of holding 292 
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potentials, together with the corresponding I-V relationship (Erev = -13.7 mV). The average 293 
Erev for AMPA-evoked responses in nucleated patches isolated from diabetic rats was -17.7 294 
± 1.8 mV (Fig. 2E; range -32.4 to -13.1 mV; n = 11 patches). The corresponding permeability 295 
ratio (PCa/PCs) was 1.39 ± 0.1 (range 0.65 – 1.74), significantly lower than the corresponding 296 
ratio in patches from normal rats (Fig. 3C; F(2,20) = 25.12, P < 0.0001, one-way ANOVA 297 
followed by Tukey’s post-hoc test). This change corresponds to a reduction in the Ca2+ 298 
permeability of the AMPA receptor channels of AII amacrine cells in diabetic animals and 299 
suggests a change in the subunit composition of the AMPA receptors. 300 
 301 
Fig. 3 near here 302 
 303 
 Insulin treatment of diabetic rats prevents the reduced Ca2+ permeability of AMPA receptor 304 
channels in nucleated patches. If hyperglycemia is causally related to the reduced Ca2+ 305 
permeability observed in nucleated patches from AII amacrines in diabetic rats, it should 306 
be possible to prevent the reduction by maintaining normoglycemia with insulin 307 
treatment. To investigate this, we injected 4-week old rats with streptozotocin in the same 308 
way as described earlier, verified the development of hyperglycemia two days after 309 
injection and then started treatment with insulin. After a period of 15 - 17 days with 310 
insulin treatment, nucleated patches were isolated from AII amacrines and tested with 311 
application of AMPA in the same way as described above. Figure 3, A and B, shows an 312 
example of responses evoked by AMPA at a series of holding potentials, together with the 313 
corresponding I-V relationship (Erev = -8.8 mV). The average Erev for AMPA-evoked 314 
responses in nucleated patches isolated from diabetic rats treated with insulin was -9.1 ± 315 
0.5 mV (Fig. 2E; range -10.9 to -8.2 mV; n = 5 patches). The corresponding permeability 316 
ratio (PCa/PCs) was 2.17 ± 0.06 (range 1.96 – 2.28), significantly different from diabetic rats 317 
that were not treated with insulin (Fig. 3C; F(2,20) = 25.12, P = 0.0003, one-way ANOVA 318 
followed by Tukey’s post-hoc test), but not significantly different from normal animals 319 
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(F(2,20) = 25.12, P = 0.567, one-way ANOVA followed by Tukey’s post-hoc test). This 320 
indicated that insulin treatment was able to prevent the diabetes-evoked reduction in the 321 
Ca2+ permeability of the AMPA receptors of AII amacrine cells, suggesting that the 322 
associated hyperglycemia could be causally involved. 323 
 324 
Fig. 4 near here 325 
 326 
 Current-voltage relationships of AMPA-evoked currents in Na+-rich external solution. The 327 
subunit composition of an AMPA receptor determines not only Ca2+ permeability, but also 328 
other functional properties like single-channel conductance, kinetics and current-voltage 329 
rectification (for review see Greger and Esteban 2007). To investigate the rectification 330 
properties of AMPA receptors in AII amacrine cells, we used a Na+-rich external solution. 331 
Because intracellular polyamines are important for the rectification properties of certain 332 
types of non-NMDA receptor channel (Kamboj et al. 1995; Koh et al. 1995), we added 333 
spermine (100 µM) to the pipette solution to prevent washout of intracellular polyamines 334 
from being a confounding factor. Figure 4A shows an example of nucleated patch 335 
responses evoked by AMPA (1.6 mM) at a series of holding potentials, with the patch 336 
taken from a normal animal. The corresponding I-V relationship for the peak response 337 
displays clear inward rectification (Fig. 4B). We calculated the RI as the ratio between the 338 
chord conductances at +40 mV and -60 mV according to eqn (1). For the nucleated patch 339 
illustrated in Fig. 4, A and B, we found Erev = -1.7 mV and RI = 0.27. For all nucleated 340 
patches from normal animals, the average values were 0.51 ± 2.70 mV (range -11.8 – 12.6 341 
mV) for Erev and 0.30 ± 0.02 (range 0.23 – 0.44) for RI (n = 9 patches; Fig. 4E). Next, we 342 
performed similar experiments with diabetic animals (2 - 3 weeks after the induction of 343 
diabetes). Figure 4C shows an example of nucleated patch responses evoked by AMPA 344 
(1.6 mM) at a series of holding potentials, with the patch taken from a diabetic animal. The 345 
corresponding I-V relationship for the peak response displays inward rectification (Fig. 346 
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4D). For this patch, we found Erev = 6.4 mV and RI = 0.39. For all nucleated patches from 347 
diabetic animals, the average values were 7.7 ± 3.9 mV (range -8.4 – 29.2 mV) for Erev and 348 
0.48 ± 0.07 (range 0.27 – 0.89) for RI (n = 10 patches; Fig. 4E). The average RI was 349 
significantly higher than that from normal rats (P = 0.04; unpaired t test), reflecting a 350 
measurable decrease in inward rectification. 351 
 352 
DISCUSSION 353 
 Here we have studied the effect of diabetes on functional properties of 354 
extrasynaptic AMPA-type glutamate receptors on the cell bodies of AII amacrine cells in 355 
the rat retina. Specifically, we used electrophysiological recording from nucleated patches 356 
to measure the relative Ca2+ permeability and I-V rectification of these receptors. Our 357 
major finding is that diabetes evokes both a decrease in Ca2+ permeability and a decrease 358 
in inward rectification of the I-V relationship. The most parsimonious interpretation of 359 
these results is that diabetes leads to a change in the subunit composition of the somatic 360 
extrasynaptic AMPA receptors of AII amacrine cells, most likely corresponding to an 361 
upregulation and increased content of the GluA2 subunit. These results raise a series of 362 
questions with respect to the relation between synaptic and extrasynaptic AMPA receptors 363 
of AII amacrine cells, how each might be influenced by diabetes and what the functional 364 
consequences of such changes could be. 365 
 366 
 Functional properties of synaptic and extrasynaptic AMPA receptors expressed by AII 367 
amacrine cells. Morphological investigations have not demonstrated synaptic input from 368 
rod or cone bipolar cells to the cell bodies of AII amacrine cells (e.g. Strettoi et al. 1992). 369 
Nevertheless, electrophysiological recordings from nucleated patches of AII amacrine cells 370 
have demonstrated the presence of non-NMDA-type ionotropic glutamate receptors with 371 
relatively high Ca2+ permeability and moderate inward rectification, and pharmacological 372 
analysis indicated the expression of AMPA, but not kainate receptors (Mørkve et al. 2002). 373 
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Furthermore, ultrafast application of glutamate to somatic outside-out patches from AII 374 
amacrine cells evokes strongly desensitizing responses with very fast deactivation and 375 
desensitization kinetics (Veruki et al. 2003). These results suggest the expression of AMPA 376 
receptors with relatively low levels of the GluA2 subunit. The receptors examined in 377 
somatic patches are most definitely extrasynaptic receptors, raising the question of how 378 
similar they are to the synaptic receptors which mediate input from rod bipolar cells at the 379 
arboreal dendrites and OFF-cone bipolar cells at the lobular appendages. Both the kinetic 380 
and pharmacological properties of synaptic non-NMDA receptors, as studied by 381 
electrophysiological recording of spontaneous excitatory postsynaptic currents (spEPSCs), 382 
suggest a strong degree of similarity with the somatic extrasynaptic receptors (Veruki et al. 383 
2003), but there is less direct evidence for high Ca2+ permeability of the synaptic AMPA 384 
receptors of AII amacrine cells. First, paired recordings of synaptically coupled rod bipolar 385 
cells and AII amacrine cells indicate moderate inward I-V rectification, suggesting 386 
expression of Ca2+-permeable receptors (Singer and Diamond 2003). Second, stimulation 387 
with kainate evokes influx of Co2+ through Ca2+-permeable AMPA receptors and the 388 
pattern of Co2+ accumulation suggests that the relevant receptors are located not only at 389 
the cell bodies of AII amacrines, but at dendritic processes as well (Osswald et al. 2007). 390 
Finally, immunocytochemical investigations have found evidence for the presence of 391 
GluA4 (and GluA3), but not GluA2, in synapses between rod bipolar cells and AII 392 
amacrine cells (Ghosh et al. 2001; Li et al. 2002; Qin and Pourcho 1999). To our knowledge, 393 
there are no published reports of corresponding functional and morphological data for the 394 
synapses between OFF-cone bipolar cells and AII amacrine cells. Taken together, these 395 
results suggest a high degree of similarity between the functional properties of 396 
extrasynaptic somatic AMPA receptors and synaptic AMPA receptors in AII amacrine 397 
cells. It is unknown, however, if the functional properties of the somatic AMPA receptors 398 
correspond to the functional properties of putative extrasynaptic AMPA receptors located 399 
at AII processes close to the synaptic inputs of rod bipolar and/or OFF-cone bipolar cells. 400 
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 401 
 Diabetes-evoked changes of AMPA receptors of AII amacrine cells. We recently found 402 
evidence for diabetes-evoked changes of the functional properties of synaptic AMPA 403 
receptors in A17, but not AII amacrine cells in rat retina (Castilho et al. 2015). The changes 404 
were observed by electrophysiological recording of spEPSCs and corresponded to a 405 
reduction in the single-channel conductance and altered pharmacological properties, 406 
consistent with an upregulation of the GluA2 subunit and reduced Ca2+ permeability. In 407 
addition, two-photon imaging revealed reduced agonist-evoked influx of Ca2+ in the 408 
dendritic varicosities of A17 amacrine cells from diabetic animals. There are at least three 409 
ways the results of the present study can be interpreted in light of the lack of any diabetes-410 
evoked functional changes of synaptic AMPA receptors of AII amacrines reported in our 411 
recent study (Castilho et al. 2015). First, it is possible that the changes we have observed 412 
for somatic extrasynaptic AMPA receptors are predictive of similar changes occuring for 413 
extrasynaptic AMPA receptors located elsewhere in AII amacrine cells. This could mean 414 
that diabetes reduces the Ca2+ permeability not only of somatic, but also of putative 415 
dendritic extrasynaptic AMPA receptors. This possibility cannot be eliminated because 416 
changes of dendritic extrasynaptic receptors would not have been detected in our previous 417 
study with recording of spEPSCs. Second, despite the fact that we did not detect any 418 
physiological, pharmacological or biophysical differences between spEPSCs in AII 419 
amacrines of normal and diabetic animals (Castilho et al. 2015), it is not possible to exclude 420 
the possibility that diabetes could reduce the Ca2+ permeability of synaptic AMPA 421 
receptors in these cells, independent of any potential changes of dendritic extrasynaptic 422 
AMPA receptors. On the basis of established properties of Ca2+-permeable AMPA 423 
receptors (Cull-Candy et al. 2006), it is unlikely that a change in Ca2+ permeability would 424 
occur without concomitant changes in other functional properties, but without being able 425 
to directly measure the Ca2+ permeability of the synaptic AMPA receptors, the possibility 426 
cannot be excluded. A complicating factor is that Ca2+-permeable AMPA receptors can be 427 
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involved in mediating synaptic input from both OFF-cone bipolar cells at the lobular 428 
dendrites and from rod bipolar cells at the arboreal dendrites of AII amacrines, and 429 
receptors at the different synapses could be differentially regulated. If diabetes reduces the 430 
Ca2+ permeability at either location of synaptic AMPA receptor by changing the receptor 431 
subunit composition, the change was not detected by our physiological, pharmacological 432 
and biophysical analysis. Although unlikely, it is difficult to completely rule out the 433 
possibility of a change in subunit composition that leads to a dissociation between Ca2+ 434 
permeability and other physiological, pharmacological and biophysical properties. There 435 
is some evidence that these functional properties of AMPA receptors are not as closely 436 
correlated as originally believed, such that determination of one property does not 437 
necessitate expression of the other (reviewed by Bowie 2012). The third interpretation of 438 
the present results is that the synaptic and extrasynaptic (somatic) AMPA receptors of AII 439 
amacrine cells are genuinely different, either with respect to their subunit composition, 440 
their posttranslational modification or with respect to their regulation and/or trafficking 441 
(Bowie 2012). 442 
 It would be challenging to directly investigate the Ca2+ permeability of synaptic 443 
AMPA receptors and how this property might change in different conditions. First, bi-444 
ionic conditions as used in the present study cannot be adequately obtained with whole-445 
cell recording and outside-out patches cannot be isolated from postsynaptic sites at AII 446 
amacrine dendrites. Second, whereas it should be possible to detect changes of I-V 447 
rectification of evoked EPSCs with simultaneous dual recording of synaptically coupled 448 
pairs, either pairs of rod bipolar cells and AII amacrine cells or pairs of OFF-cone bipolar 449 
cells and AII amacrine cells, I-V rectification and Ca2+ permeability might be dissociated as 450 
mentioned earlier (Bowie 2012). Recording of synaptically coupled cell pairs is also 451 
unlikely to be adequate for detailed pharmacological analysis because synaptic release 452 
from bipolar cells runs down relatively quickly. Third, measuring Ca2+ influx by a 453 
combination of two-photon imaging and microiontophoretic application of agonist to 454 
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dendrites of AII amacrine cells, as we did for dendritic varicosities of A17 amacrine cells 455 
(Castilho et al. 2015), can potentially provide valuable information, but cannot easily 456 
distinguish between synaptic and extrasynaptic receptors when applied to neurons in slice 457 
preparations. The technique of two-photon uncaging of neurotransmitter agonists has the 458 
highest spatial resolution, but even in this case it is difficult to ensure that only synaptic 459 
AMPA receptors are activated.  460 
 461 
 Functional consequences of diabetes-evoked changes of AMPA receptors in AII amacrine 462 
cells. In the present study we have examined diabetes-evoked changes of somatic 463 
extrasynaptic receptors. Given the lack of synaptic input from bipolar cells to the cell 464 
bodies of AII amacrines, it is not known whether these extrasynaptic receptors would 465 
encounter a glutamate concentration sufficiently high for channel opening under normal 466 
conditions. However, there is evidence for elevated levels of glutamate both in the retina 467 
of animals with experimentally induced diabetes (Lieth et al. 1998) and in the vitreous of 468 
patients with proliferative diabetic retinopathy (Ambati et al. 1997). Accumulation of 469 
glutamate in the extracellular space could be caused by reduction of glutamine synthetase 470 
in Müller cells, with consequent reduced conversion of glutamate to glutamine, by 471 
reduced oxidation of glutamate to α-ketoglutarate or by impaired uptake of glutamate by 472 
Müller cells (Li and Puro 2002; Lieth et al. 2000). 473 
 If ambient glutamate evokes channel opening, it is possible that an increased 474 
concentration of ambient glutamate in the diabetic retina could lead to reduced input 475 
resistance and thus changes in the integrative properties of AII amacrines. Another 476 
possibility is that the level of ambient glutamate primarily evokes steady-state 477 
desensitization of the extrasynaptic AMPA receptors. The reduced Ca2+ permeability of 478 
AMPA receptors observed here could be a mechanism for counteracting increased Ca2+ 479 
influx evoked by increased extracellular glutamate in the diabetic retina. In effect, the 480 
reduced Ca2+ permeability could be a protective mechanism rendering neurons less 481 
 20 
susceptible to glutamate excitotoxicity. At the moment, however, we do not know if the 482 
change in Ca2+ permeability is caused indirectly, e.g. as a consequence of changes in 483 
extracellular glutamate, or if diabetes has a direct effect on different types of neurons and 484 
their expression of transmitter receptors. 485 
 It is not known whether the diabetes-evoked reduction of Ca2+ permeability for 486 
somatic extrasynaptic AMPA receptors of AII amacrines also applies to putative 487 
extrasynaptic dendritic AMPA receptors and/or synaptic AMPA receptors. The fast 488 
kinetics of Ca2+-permeable AMPA receptors result in a very brief Ca2+ influx through these 489 
receptors, but the functional consequences of the expression of such receptors at synaptic 490 
or extrasynaptic sites in AII amacrine cells is currently unclear. Recently, a model with a 491 
preferential location of Ca2+-permeable and Ca2+-impermeable AMPA receptors at synaptic 492 
and perisynaptic locations of bipolar cell inputs to retinal ganglion cells was postulated 493 
(Jones et al. 2014). Varying the strength of presynaptic activation leads to differential 494 
activation of the different types of postsynaptic AMPA receptors, depending on the degree 495 
of spillout of glutamate at these synapses. If similar mechanisms are operative at the 496 
bipolar cell inputs to AII amacrines, changes in the Ca2+ permeability of AMPA receptors 497 
evoked by diabetes could influence the signaling and integrative properties of AII 498 
amacrine cells including the activity-driven intracellular Ca2+ dynamics related to 499 
regulating the strength of gap junction-mediated electrical coupling between AII amacrine 500 
cells (Kothmann et al. 2009, 2012) which is likely to be an important mechanism for post-501 
receptoral visual adaptation (reviewed by Demb 2010). 502 
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FIGURE LEGENDS 672 
Fig. 1. AII amacrine cells in retinal slices: visualization, identification, isolation of 673 
nucleated patches, and AMPA-evoked current. A: infrared differential interference 674 
contrast videomicrograph of an AII amacrine cell in a retinal slice. Arrow points to cell 675 
body and apical dendrite. The retinal layers are indicated by abbreviations (OPL, outer 676 
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer). B: 677 
electrophysiological "signature" of an AII amacrine cell as observed in whole-cell voltage 678 
clamp recording (holding potential -60 mV). Transient inward currents correspond to 679 
unclamped action currents (escape from voltage clamp) evoked by 5 mV depolarizing 680 
voltage pulses. C: infrared differential interference contrast videomicrograph of a 681 
nucleated patch isolated from an AII amacrine cell (as in A). D: current activated in a 682 
nucleated patch by application (500 ms) of AMPA (1.6 mM) from a theta tube pipette. The 683 
trace is the average of four trials. Here, and in subsequent figures, the duration of drug 684 
application is indicated by the horizontal bar above the current trace. Scale bar (A): 10 µm, 685 
(C): 5 µm.  686 
 687 
Fig. 2. Ca2+ permeability of AMPA receptor channels in nucleated patches from AII 688 
amacrine cells is reduced in animals with streptozotocin-evoked diabetes. A: responses 689 
evoked by application of 1.6 mM AMPA (400 ms) to a nucleated patch from a normal rat 690 
under bi-ionic conditions ([Ca2+]out = 30 mM, [Cs+]in = 171 mM). Holding potential was 691 
varied between -80 mV and 60 mV (20 mV steps). Each trace is the average of three trials. 692 
B: Current-voltage (I-V) relationship of peak responses of nucleated patch in A (fitted with 693 
a 3rd order polynomial function). C: responses evoked by application of 1.6 mM AMPA 694 
(400 ms) to a nucleated patch from a rat with experimental diabetes under bi-ionic 695 
conditions (same recording conditions as A). Each trace is the average of five trials. D: I-V 696 
relationship of peak responses of nucleated patch in C (fitted with a 4th order polynomial 697 
function). E: Reversal potentials of AMPA-evoked currents (here and later, bars represent 698 
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means ± SEMs) in nucleated patches from AII amacrine cells from normal animals (n = 7 699 
patches), diabetic animals (n = 11 patches) and insulin-treated diabetic animals (n = 5 700 
patches). Here and later, data from individual recordings are represented by circles. Here 701 
and later, the results from statistical comparisons between averages are indicated by n.s. 702 
(no significant difference; P ≥ 0.05) or a single asterisk (statistically significant difference; P 703 
< 0.05). 704 
 705 
Fig. 3. Ca2+ permeability of AMPA receptor channels in nucleated patches from AII 706 
amacrine cells is restored when animals with streptozotocin-evoked diabetes receive 707 
insulin treatment. A: responses evoked by application of 1.6 mM AMPA (250 ms) to a 708 
nucleated patch from a diabetic rat treated with insulin, under bi-ionic conditions ([Ca2+]out 709 
= 30 mM, [Cs+]in = 171 mM). Membrane potential was varied between -80 mV and 60 mV. 710 
No averaging of traces. B: I-V relationship of peak responses from nucleated patch in A 711 
(fitted with a 3rd order polynomial function). C: Ca2+ permeability (expressed as Ca2+ 712 
permeability relative to Cs+ permeability, PCa/PCs) of AMPA receptor channels in 713 
nucleated patches from AII amacrines in normal animals (n = 7 patches), diabetic animals 714 
(n = 11 patches) and insulin-treated diabetic animals (n = 5 patches).  715 
 716 
Fig. 4. Inward rectification of AMPA receptor channels in nucleated patches from AII 717 
amacrine cells is reduced in animals with streptozotocin-evoked diabetes and restored 718 
when diabetic animals receive insulin treatment. A: responses evoked by application of 1.6 719 
mM AMPA (350 ms) to a nucleated patch from a normal animal. Spermine (100 µM) 720 
included intracellularly (A - D). Holding potential was varied between -80 mV and 60 mV. 721 
Each trace is the average of six trials. B: I-V relationship of peak responses from nucleated 722 
patch in A (fitted with a 6th order polynomial function) C: responses evoked by 723 
application of 1.6 mM AMPA (500 ms) to a nucleated patch from a diabetic animal. Same 724 
recording conditions as in A. Each trace is the average of seven trials. D: I-V relationship of 725 
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peak responses of nucleated patch in C (fitted with a 4th order polynomial function). E: 726 
rectification index of AMPA-mediated responses in nucleated patches from AII amacrines 727 
in normal animals (n = 9 patches) and diabetic animals (n = 10 patches). 728 
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